Skip to main content

Marex Group plc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1997464 London, X0

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,343,620
-$22,730,232 QoQ
Shares Held
1,739
-94.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$23,156,100
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Marex Group plc holds $67,081,190 across 58 Biotechnology names. REGN ranks #8 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 REGN
Regeneron Pharmaceuticals, Inc.
This page
1,739 $1,343,620

All Filings in REGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,343,620 1,739
2025-12-31 $23,156,100 30,000
2025-12-31 $24,073,852 31,189
2025-09-30 $28,113,500 50,000
2025-09-30 $28,652,154 50,958
2025-06-30 $27,002,325 51,433
2025-06-30 $26,250,000 50,000
2025-03-31 $44,946,611 70,868
2024-12-31 $50,051,866 70,265
2024-09-30 $37,006,801 35,203
2023-12-31 $22,146,960 25,216
2022-12-31 $238,091 330